Cell therapy is one of the most promising emerging routes to personalized medicine for the treatment of hematological malignancies and solid tumors. While cell therapy is a rather broad term with a variety of interpretations, the simplest definition is a therapy that involves the introduction of live cells into a patient’s body to treat or prevent disease. Cell therapies utilize the potential of different types of cells (including stem cells, immune cells, and somatic cells) to repair, replace, or regenerate damaged tissues or organs. Cell-based therapies may use cell transplants from donor sources, but an ever-growing arsenal of emerging therapies relies on the patient’s own cells, whether reprogrammed, genetically engineered, or otherwise manipulated.
Stem cell therapy is a prominent area of cell therapy. Stem cells have the ability to differentiate into various cell types, allowing them to repair damaged tissues. They are applied to conditions like heart disease, osteoarthritis, spinal cord injuries, and Parkinson’s disease.
Bone marrow transplants are widely used for treating hematological disorders like leukemia, lymphoma, and other blood cancers. Bone marrow transplants involve infusing healthy hematopoietic (blood-forming) stem cells from a compatible donor or autologous transplant to regenerate the patient’s blood and immune systems.
CAR-T cell therapy (Chimeric Antigen Receptor T-cell therapy) is a revolutionary treatment for certain types of cancers, like leukemia and lymphoma. It involves modifying a patient’s T cell to better recognize and attack cancer cells.
T-cell and NK cell therapies boost the body’s natural immune response to fight cancer by using genetically engineered immune cells.
Regulatory T-cell therapy is being explored as a potential treatment for autoimmune diseases like multiple sclerosis or type 1 diabetes. The goal is to use engineered T cells to suppress the immune system’s abnormal response that attacks healthy tissues.
Gene therapy relies on genetically modified cells to correct defects or provide therapeutic benefits. For example, gene-edited stem cells are used to treat certain inherited disorders like sickle cell anemia.
Cell therapies are being tested in conditions like heart failure and chronic lung diseases, where stem cells or other cells are injected to promote tissue repair and potentially regenerate damaged organs.
While cell therapies are relatively heterogenous in a variety of aspects -, including the employed cell type, the cell source, and how the cells are manipulated, the vast majorities of cell therapies have the common characteristic that they require the maintenance and often amplification of the utilized cells in cell culture systems in vitro.
Besides identifying the optimal cell type and source as well as the manipulation strategy, one of the major hurdles in the development of any given cell therapy is typically the establishment of the optimal cell culture conditions – and that frequently not once, but for multiple steps in the ex vivo cell manipulation process.
Mammalian cells have evolved over millions of years to exist within an intricate network of interwoven cells, entangled in multitudinous extracellular signals often vital for their survival, maintenance, and biological status. Cell culture of therapeutic cells not only needs to replicate that environment to maintain healthy cells, but to finely manipulate it to achieve the desired cellular changes and transitions. Using the right cell culture additives in the right amounts at the right time is paramount in the development of cell cultures for cell therapy applications.
Here we want to provide an overview of commonly used cell culture additives such as small molecules, cytokines, and growth factors to optimize cell culture conditions in therapeutic applications.
Growth Factors and cytokines are diffusible signaling molecules that regulate cell proliferation, differentiation, and migration. These signaling molecules are typically secreted proteins and can act locally through autocrine and paracrine signaling, as well as endocrine through the circulatory system. Traditionally the term cytokine has been used to describe signaling molecules influencing hematopoietic cells and modulate the immune response, and growth factors was used to describe signaling molecules prominently involved in cellular differentiation, especially during embryonic development. It is becoming increasingly clear that there is pronounced overlap between these domains and the terms growth factor and cytokine can basically be used interchangeably.
Cytokines and growth factors generally act through membrane-bound receptors that relay the extracellular signals through numerous signaling pathways, including GSK-3, RAS/MAPK, PI3-Kinase/AKT and PLCγ signaling.
Cytokines and growth factors are often crucial cell culture additives for the survival and maintenance of any given cultured cell type, but their importance comes into its own when driving controlled cell differentiation in cell culture is the goal. Finding the right cocktail of cytokines and growth factors is absolute key when establishing cell therapies involving ex vivo differentiation. 2
Commonly used general growth factors:
Hematopoietic Growth Factors and Cytokines:
Small molecules are low-molecular-weight bioactive compounds that modulate cultured cells, by promoting cell growth, differentiation, and survival, and even reprogramming cell fate. Some combination of small molecules is typically used to modify or enhance the function of cells during the culture process to obtain cells for therapeutic applications. Small bioactive compounds play a crucial role in directing the differentiation of stem cells into the desired cell types, enhancing cell survival, and improving therapeutic efficacy. Manifold proven small molecules to enhance cell cultures exist and the untapped potential of additional compounds to boost cell therapy applications is probably even higher. To provide an overview 3 over small molecule cell culture additives, it is helpful to classify them by function:
Another category of small compounds used to modulate and optimize cell cultures for therapy applications can be classified as modifiers of epigenetic processes. Cell fate change, whether occurring in dedifferentiation into more stem-cell like state, or differentiation and maturation into more fate-committed precursors and differentiated cells, is often hindered by the inertness of the epigenetic status of the respective cell. Compounds that influence the activity of the epigenetic machinery can drastically improve the effectiveness of attempts to modulate cell status and cell fate typically required in cell therapy. The most commonly targeted cellular epigenetic actors are histon
